FDA gives emergency authorization to COVID-19 drug
May 4, 2020
…But 8% mortality is still a lot of people, so the use of additional agents is aimed at further improving outcomes,” he said. The drug acts by disrupting the coronavirus…
May 4, 2020
…But 8% mortality is still a lot of people, so the use of additional agents is aimed at further improving outcomes,” he said. The drug acts by disrupting the coronavirus…
May 4, 2020
Drs. Thomas Patterson, chief of the Division of Infectious Diseases, and Jason Bowling, Infectious Diseases, explained the implications of the FDA fast-tracking emergency authorization of the new anti-viral drug, remdesivir,…
May 2, 2020
…8% mortality is still a lot of people, so the use of additional agents is aimed at further improving outcomes,” he said. The drug acts by disrupting the coronavirus replication…
May 1, 2020
Dr. Thomas Patterson, chief of the Division of Infectious Diseases and PI of the remdesivir clinical trial site locally, was interviewed recently for the “Petrie Dish” podcast about the promising…
May 1, 2020
Dr. Ruth Berggren, infectious diseases specialist and director of the Center for Medical Humanities and Ethics, was a guest on “The Source” and answered questions about the coronavirus and mortality…
May 1, 2020
Dr. Fred Campbell, General and Hospital Medicine, answers listeners’ questions about their health during the coronavirus pandemic. Listen to the Q&A….